DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...

Introduction The therapeutic use of cells to address medical issues or illnesses is known as cell therapy . Cells or tissues are transplanted i ...

Reston Hospital Center, a part of US-based healthcare network HCA Virginia, has opened an inpatient unit at its main hospital ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Jefferies analyst Roger Song maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...

Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (Nasdaq: BDRX), a clinical ...

Cancer and its associated treatments represent a multifaceted challenge that affects both the physical and psychological well-being of patients. Over the ...

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...

This article will explore what DLBCL is and how clinical trials can potentially lead to breakthroughs in treatment.

Advancements in precision medicine drive the 5-HT2 agonist market by enabling selective targeting of specific receptor subtypes (e.g., 5-HT2A or 5-HT2C), reducing side effects and improving safety.

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...